Clinical trial
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib…
NCT00328432 · University of Kansas, Other · Completed
Key facts
| NCT number | NCT00328432 |
|---|---|
| Title | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy |
| Official title | Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer |
| Lead sponsor | University of Kansas, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib 400 mg bid |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | May 22, 2006 |
| Last update posted | Sep 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: